https://scholars.lib.ntu.edu.tw/handle/123456789/517613
標題: | Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in TWN: A prospective observational study | 作者: | TSEN-FANG TSAI CHIEN-AN YAO Yu H.-S. Lan C.-C. Chao S.-C. Yang J.-H. Yang K.-C. Chen C.-Y. White R.R. Psaradellis E. Rampakakis E. Kawai K. Acosta C.J. Sampalis J.S. |
公開日期: | 2015 | 出版社: | Blackwell Publishing Ltd | 卷: | 54 | 期: | 5 | 起(迄)頁: | 529-536 | 來源出版物: | International Journal of Dermatology | 摘要: | Background: To assess the severity and duration of herpes zoster (HZ)-associated pain (ZAP) and its impact on quality of life (QoL) and healthcare utilization (HCRU) from a patient perspective in routine care in TWN. Methods: A prospective, observational, single-cohort study was conducted in five centers across TWN. Patients were recruited at different time points during their HZ episode and were followed for ?180?days. ZAP was assessed with the Initial Zoster Impact Questionnaire and the Zoster Brief Pain Inventory, QoL with the EQ-5D, and HCRU with a simple questionnaire. Results: A total of 150 patients were included with a mean age of 64.9?years and mean time since rash onset of 18.8?days. Prodromal pain was experienced by 64.7% of patients, of whom 91.8% reported moderate-to-severe pain. At enrollment, 98.0% of patients experienced ZAP. Mean?±?SD worst pain score decreased from 5.95?±?3.09 at enrollment to 2.65?±?2.98 at 30?days and 0.28?±?0.83 at 180?days. Postherpetic neuralgia was observed in 20.7% of patients. Mean?±?SD EQ-5D score significantly decreased (P?0.001) from 0.91?±?0.16 before rash onset to 0.67?±?0.18 after rash onset, showing significant QoL deterioration up to 60?days. The impact of HZ on QoL and pain severity was similar across age groups. Significant HCRU was observed including visits to the doctor (83.3% of patients), specialist (30.7%), emergency department (24.7%), physiotherapist (23.3%), and hospitalizations (20.7%). Conclusion: Severe morbidity and significant HCRU are associated with HZ in TWN, supporting the need for early intervention and preventive strategies to reduce the HZ-associated burden of illness. ? 2014 The International Society of Dermatology. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928325439&doi=10.1111%2fijd.12484&partnerID=40&md5=b1f0796838390f6340873963e1eace25 https://scholars.lib.ntu.edu.tw/handle/123456789/517613 |
ISSN: | 0011-9059 | DOI: | 10.1111/ijd.12484 | SDG/關鍵字: | aciclovir; famciclovir; topical agent; valaciclovir; adult; aged; antiviral therapy; Article; cohort analysis; daily life activity; dermatome; deterioration; disease duration; disease severity; emergency ward; female; follow up; health care utilization; health status; herpes zoster; hospitalization; human; Initial Zoster Impact Questionnaire; major clinical study; male; medical specialist; observational study; pain severity; physician; physiotherapist; postherpetic neuralgia; prospective study; quality of life; rash; Taiwan; Zoster Brief Pain Inventory; complication; herpes zoster; Neuralgia, Postherpetic; patient attitude; quality of life; questionnaire; severity of illness index; statistics and numerical data; time; Female; Herpes Zoster; Humans; Male; Neuralgia, Postherpetic; Patient Acceptance of Health Care; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Taiwan; Time Factors |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。